T. van der Sluis

The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth

Ryan M. O’Connell, K. Kok, I. Nolte, 2020, Cancers.

cGAS–STING drives the IL-6-dependent survival of chromosomally instable cancers

M. V. van Vugt, Michael Schubert, T. van der Sluis, 2022, Nature.

MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth

K. Kok, A. van den Berg, D. de Jong, 2020, Cancers.

cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancer

M. V. van Vugt, B. van der Vegt, M. Zwager, 2024, NPJ breast cancer.

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

S. de Jong, T. van der Sluis, E. Bridges, 2023, Journal of Experimental & Clinical Cancer Research.

Argonaute 2 RNA Immunoprecipitation Reveals Distinct miRNA Targetomes of Primary Burkitt Lymphoma Tumors and Normal B Cells.

K. Kok, A. van den Berg, D. de Jong, 2018, The American journal of pathology.